Ascites Impact Measure (AIM)

Sanofi Aventis

Distributed by Mapi Research Trust


Distributed by Mapi Research Trust

Basic description

Developed started in 2004; Published in 2012

AIM is adapted for daily completion using a 24-hour recall period however the use of the AIM at a weekly or monthly frequency is authorized (Information provided by the author)


Sanofi Aventis

AIM © Sanofi-Aventis. All rights reserved.
To record patients’ daily experiences of symptoms that trigger a request for a paracentesis in patients with ascites
Therapeutic area
  • Pathological Conditions, Signs and Symptoms
Therapeutic indication


Type of Clinical Outcome Assessment (COA)
  • pro PRO
Original language(s)
  • English for the USA
Bibliographic reference(s) of the original questionnaire

Crawford B, Piault E, Gotlieb W, Joulain F. Development and validation of the self-completed ascites impact measure to understand patient motivation for requesting a paracentesis. Patient Relat Outcome Meas. 2012 Jul;3:21-30 (Full Text)

Access this questionnaire

Please proceed below

Login SIGN up free

Contact and conditions of use


Sanofi Aventis

Contact information

Mapi Research Trust
27 rue de la Villette
69003 Lyon
Phone: +33 (0)4 72 13 66 66

Conditions of use

Students, physicians, clinical practice, not-funded academic users

You may access the questionnaire and/or its available translations directly (see tutorial). Should you not see the Download button, please contact us.

Funded academic users, healthcare organizations, commercial users & IT companies

Fees may apply to your project. Submit your request (see tutorial). Our PROVIDE team will get back to you with the needed information and license agreement in a timely manner.

Author Website(s)

Review copy

Examination copies can only be used for the limited purpose of examining the suitability of the Questionnaire for subsequent research and/or clinical use, and cannot be used in research or in clinical practice or distributed to others.
You are not authorized to modify, retype, translate, copy or otherwise duplicate the Questionnaire except with the further and prior written permission of Mapi Research Trust / the developers / copyright holders / distributors.


Original language(s)

  • English for the USA


The list of available translations is subject to constant changes and may not be exhaustive. It is provided for information only. Some recently produced translations may not be included in the list below yet. Please do check the status of available translations with Mapi Research Trust / the developers / copyright holders / distributors.

Also, the listed translations may not have undergone a full linguistic validation process and may require further work to be suitable for use in a study.


Arabic for Israel*
Bengali for India*
Danish for Denmark*
Dutch for Belgium (Flemish)*
Dutch for the Netherlands*
English for the UK*
Finnish for Finland*
French for Belgium*
French for France*
German for Germany*
Gujarati for India*
Hebrew for Israel*
Hindi for India*
Hungarian for Hungary*
Italian for Italy*
Kannada for India*
Malayalam for India*
Marathi for India*
Norwegian for Norway*
Portuguese for Portugal*
Russian for Israel*
Russian for Russia*
Spanish for Spain*
Spanish for the USA*
Swedish for Sweden*
Tamil for India*
Telugu for India*
Urdu for India*
* Performed by Mapi/ICON

The author has selected Mapi/ICON Language Services as exclusive linguistic validation company to ensure the production of harmonized and consistent language versions.

For additional information on available translations of this instrument, or for a project involving new languages, please submit a request (tutorials available on our FAQs).

Conditions to translate

Commercial Users

Exclusive vendor for translation work for commercial users: Mapi/ICON Language Services

Academic Translation:

Not authorized

Member Access

Subscribe to PROQOLID to access to full information

Access to advanced descriptions of Clinical Outcome Assessments (COAs)

A question? Contact us